In 2025, Genscript Biotech conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2025 | 2024 |
|---|---|---|
Total Waste Generated | 15,596.67a | 14,893.53a |
Total Waste Recovered | 11,660.43a | 11,281.18a |
Total Hazardous Waste Generated | 4,586.25a | 3,719.18a |
Non-Hazardous Waste Disposed | 1,303.02a | 1,481.51a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2025, Genscript Biotech generated a total of 15,597metric tonnes of waste.a
Of this amount, 74.76% of Genscript Biotech's total waste generated was recovered through methods such as recycling, reuse, or composting, while 25.24% was disposed of through landfilling, incineration, or combustion.a
In 2025, Genscript Biotech reported a total waste generation of 15,597 metric tonnes, of which 74.76% was recovered through recycling, reuse, or composting.This moderate level of recovery indicates that Genscript Biotech is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.a
Since 2025, Genscript Biotech's total waste generation has increased by 4.72%, which may reflect expanding operations, weaker material efficiency, or insufficient waste reduction efforts.a
Over the same period, Genscript Biotech's waste recovery rate decreased by 1.3%.a
In 2025, Genscript Biotech generated a total of 15,597 metric tonnes of waste.a
Of this amount, 29.41% of Genscript Biotech's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment.70.59% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.a
Since 2025, Genscript Biotech's total waste generation has increased by 4.72%, which may reflect expanding operations, weaker material efficiency, or insufficient waste reduction efforts.a
Since 2025, Genscript Biotech's hazardous waste generation has increased by 17.75%, indicating a potential rise in the use of harmful materials, process inefficiencies, or limited hazardous waste reduction strategies..a
Overall, Genscript Biotech has seen a recent increase in both total waste and hazardous waste, which may indicate growing operational pressures or insufficient controls on harmful materials.a
In 2025, Genscript Biotech reported that 4,586 metric tonnes of its total waste output were classified as hazardous. This represents 29.41% of its overall waste generation.a
The company treated this hazardous waste using a combination of methods.Approximately 42.58% was managed through recovery methods, indicating a moderate integration of circular practices into its hazardous waste management. However, a significant share was still directed toward disposal, highlighting room for improvement in reducing the long-term impact of hazardous materials.a